Caristo Diagnostics recognized as quarter-finalist in the Digital Health Awards Rising Star category

OXFORD, England, 3 September 2024 /PRNewswire/ — Caristo diagnosticsa global leader in the diagnostics and risk prediction of cardiovascular diseases, was selected as a quarter-finalist for the prestigious Digital Health Hub Foundation: Digital Health AwardsCaristo was selected as a quarterfinalist in the Rising Star Provider Diagnostics category.

This recognition underscores the company's commitment to creating a new paradigm to prevent heart attacks and fight heart disease by uncovering hidden inflammation. The Digital Health Awards honor organizations that are making strides in improving efficiency, effectiveness, and equity in healthcare with their digital innovations. As a quarterfinalist, Caristo stands out for its commitment to applying advanced AI technology to diagnose cardiovascular disease and assist healthcare professionals in stratifying and treating coronary heart disease, the #1 cause of death worldwide.

“We are deeply honored to have been nominated as a quarter-finalist in the Provider Diagnostics category of the Digital Health Awards,” said Frank ChengCEO of Caristo. “This recognition reflects not only our commitment to improving heart health, but also the real positive results our customers have achieved by using our technologies.”

From an extensive pool of over 1,500 entries, only the most promising 15 quarter-finalists per category and title made it to this phase.

A current study published in The Lancet (29 May^th) has shown that today's focus on diagnosing and treating obstructive coronary artery disease misses two-thirds of fatal and non-fatal cardiac events. By measuring coronary inflammation, Caristo's proprietary CaRi-Heart technology is uniquely able to uncover this hidden but treatable driver of disease progression.

The CaRi-Heart technology is commercially available in the European Union, United KingdomAnd Australia and is currently applying for approval from the U.S. Food & Drug Administration.

“This year has set a new benchmark for excellence, with a remarkable influx of global submissions showcasing groundbreaking innovations in digital health. The level of ingenuity and commitment we have seen is truly inspiring. Congratulations to all our quarter-finalists for their outstanding achievements,” said Mark GoldsteinChair of the Digital Health Hub Foundation.

The finalists will be announced 22 September 2024 The winners will be announced at the grand finale at HLTH on October 21, 2024.

About Caristo Diagnostics

Caristo diagnostics is a global leader in the diagnostics and risk prediction of cardiovascular diseases. Founded in 2018 as a spin-out company from the University of Oxfordthe world's leading research university, Caristo has developed a portfolio of image-based and AI-powered platforms that can be used to predict and diagnose heart attacks, strokes and diabetes. Caristo has been recognized by Newsweek as one of the best digital healthcare companies and highlighted by Nature as one of the most exciting science-based companies to emerge from academic laboratories. Find Caristo online at its website, LinkedIn And X.

The story continues

About the Digital Health Hub Foundation:

Our mission is to help the world's next leading innovative healthcare companies grow and scale. Founded in 2017 on the campus of UCSF in San FranciscoOur community, now at 30,000 members, is comprised of thousands of early- to late-stage healthcare companies, as well as highly-skilled healthcare providers, payers, experts, mentors, investors, clinicians and researchers who attend our annual awards ceremony where we bring the industry together to honor and recognize the best of the best and celebrate healthcare technology advancements and their impact.

Logo – https://mma.prnewswire.com/media/2054669/4888016/Caristo_Logo.jpg

contact
Frank ChengCEO of Caristo Diagnostics
[email protected]

View original content: